Outcome of posterior chamber phakic intraocular lens procedure to correct myopia

Sabaani, Nasser Al; Assiri, Abdullah; Torbak, Abdullah Al; Motawa, Saeed Al

doi:10.1016/j.sjopt.2013.06.009

Cited by 9 publications

(14 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Previously published ICL reports have also documented an improvement in BCVA after ICL implantation. 3 BCVA was maintained or improved in all eyes in the series published by Senthil S et al 1 , Sabaani A et al 2 and Le Loir M et al 4 whereas only one eye lost BCVA in studies by Baradaran-Rafii A and Hashemian SJ et al 5 and Zaldivar et al 3,5 In our study, Postoperative examinations were conducted at day 1, day 3, after 1 week, 1 month and after 3 months. Comparing the proportion of eyes with 6/24 or better BCVA, only 68% had this level pre operatively, compared with 96% of eyes had this level at the postoperative visit which indicates the efficacy of phakic IOL.…”

Section: Resultsmentioning

confidence: 46%

“…several studies reported an improvement in BCVA after ICL implantation with no accompanying intraoperative or postoperative complications. 3 Preservation of BCVA, commonly considered the primary criterion for assessing the safety of a refractive surgical procedure, was extremely high in the study cohort presented in this article. Previously published ICL reports have also documented an improvement in BCVA after ICL implantation.…”

Section: Resultsmentioning

confidence: 91%

“…Furthermore, as previously reported in the literature, the safety of the ICL procedure is enhanced by the low incidence of postoperative and intra operative complications. 3,7 The latest generation of myopic ICLs (model V4) is presumed to completely vault the anterior crystalline lens capsule and to rest on the anterior zonular fibers. This, of course, necessitates correct selection of the overall size of the ICL, which ranges from.…”

Section: Figure 7 Post Op Picture Of Phakic Iol With 4 Holesmentioning

confidence: 99%

See 2 more Smart Citations

Clinical Study of Posterior Chamber Phakic Iol Placement in Myopic Patients

P¹,

M²,

R³

et al. 2017

jebmh

View full text Add to dashboard Cite

BACKGROUND The aim of this study was to determine the safety and efficacy of posterior chamber phakic IOL in Myopic patients. MATERIALS AND METHODS This prospective interventional study included 50 eyes of 50 patients with myopia. Patients of age more than 18 yrs. Stable refraction, Myopia, Mild to Moderate keratoconus and absence of any ocular pathology and any history of ocular surgeries were included in this study. Prior to starting treatment certain parameters like visual acuity, AC depth, Iridocorneal Angle Aperture, Endothelial cell count, Central corneal thickness and IOP were considered. Intervention-Implantation of the phakic IOL. Main outcome Measures-Uncorrected Visual Acuity (UCVA), best spectacle corrected visual acuity (BSCVA), AS OCT AC depthbetween endothelium and phakic IOL, IOP and Endothelial cell count were recorded. RESULTS Postoperative examinations conducted at day 1, day 3, after 1 week, 1 month and after 3 months .out of 50 patients, 4 patients had striate keratopathy, 2 patients had shallow ac during immediate post-operative period. During the postoperative follow up 10 patients had BCVA of 6/9-6/6 (20%), 14 patients had 6/9-6/12 (28%), 24 patients had 6/12-6/24(48%) and remaining 2 patients had <6/24 which was better than their preoperative uncorrected visual acuity. CONCLUSION Based on this prospective clinical study and on comparison with other clinical studies posterior chamber phakic IOL corrective procedures are safe and effective for treatment of myopia. It also shows that it can provide sharp and clear vision in 96% of our study population. It does not induce dry eye syndrome as in other refractive surgeries. Short term complications like endothelial damage, angle closure glaucoma, iritis, anterior capsule injury/lens changes were not encountered during our study. But still long term follow up is required to confirm long term safety of the implant.

show abstract

Section: Resultsmentioning

confidence: 46%

Section: Resultsmentioning

confidence: 91%

Section: Figure 7 Post Op Picture Of Phakic Iol With 4 Holesmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Study of Posterior Chamber Phakic Iol Placement in Myopic Patients

P¹,

M²,

R³

et al. 2017

jebmh

View full text Add to dashboard Cite

show abstract

“…Die implantierbare Collamer-Linse (ICL) stellt eine effektive sichere operative Alternative [2] für die Korrektur einer moderaten bis hohen Myopie mit langfristig guten Ergebnissen [1,2,21,22] dar. Die Indikation für die ICL-Implantation besteht bei gesunden Patienten, bei denen ein keratorefraktiver Eingriff aufgrund der hohen Ametropie nicht möglich ist.…”

Section: Diskussionunclassified

“…Langfristige Nachuntersuchungen sind erforderlich [22], da z. B. auch Fälle von rezidivierenden Verschlüssen von Laseriridotomien [19] im Rahmen der Entwick- …”

Section: Diskussionunclassified